KR20100016171A - 위장관암의 치료를 위한 ｈｄａｃ 억제제의 용도 - Google Patents

위장관암의 치료를 위한 ｈｄａｃ 억제제의 용도 Download PDF

Info

Publication number
KR20100016171A
KR20100016171A KR1020097022965A KR20097022965A KR20100016171A KR 20100016171 A KR20100016171 A KR 20100016171A KR 1020097022965 A KR1020097022965 A KR 1020097022965A KR 20097022965 A KR20097022965 A KR 20097022965A KR 20100016171 A KR20100016171 A KR 20100016171A
Authority
KR
South Korea
Prior art keywords
alkyl
aryl
heteroaryl
heterocycloalkyl
cycloalkyl
Prior art date
Application number
KR1020097022965A
Other languages
English (en)
Korean (ko)
Inventor
피터 위즈덤 아타드자
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39683987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20100016171(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20100016171A publication Critical patent/KR20100016171A/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020097022965A 2007-05-04 2008-05-02 위장관암의 치료를 위한 ｈｄａｃ 억제제의 용도 KR20100016171A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91599607P 2007-05-04 2007-05-04
US60/915,996 2007-05-04

Publications (1)

Publication Number Publication Date
KR20100016171A true KR20100016171A (ko) 2010-02-12

Family

ID=39683987

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097022965A KR20100016171A (ko) 2007-05-04 2008-05-02 위장관암의 치료를 위한 ｈｄａｃ 억제제의 용도

Country Status (16)

Country Link
EP (1) EP2142190A1 (es)
JP (1) JP2010526149A (es)
KR (1) KR20100016171A (es)
CN (1) CN101674825A (es)
AU (1) AU2008247603A1 (es)
BR (1) BRPI0811112A2 (es)
CA (1) CA2683554A1 (es)
CL (1) CL2008001269A1 (es)
IL (1) IL201318A0 (es)
MA (1) MA31356B1 (es)
MX (1) MX2009011692A (es)
RU (1) RU2009144842A (es)
TN (1) TN2009000427A1 (es)
TW (1) TW200908964A (es)
WO (1) WO2008137630A1 (es)
ZA (1) ZA200906739B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
US20070167499A1 (en) * 2003-10-27 2007-07-19 A*Bio Pte Ltd. Biaryl linked hydroxamates: preparation and pharmaceutical applications
EP1685094A4 (en) * 2003-10-27 2007-08-22 S Bio Pte Ltd HYDROXAMATES CONNECTED TO ACYLUREE AND SULFONYLUREE
WO2006075165A1 (en) * 2005-01-13 2006-07-20 Btg International Limited Combination of oncolytic viruses with angiogenesis inhibitors

Also Published As

Publication number Publication date
TW200908964A (en) 2009-03-01
RU2009144842A (ru) 2011-06-10
IL201318A0 (en) 2010-05-31
CA2683554A1 (en) 2008-11-13
WO2008137630A1 (en) 2008-11-13
CN101674825A (zh) 2010-03-17
CL2008001269A1 (es) 2008-12-19
BRPI0811112A2 (pt) 2014-12-23
MA31356B1 (fr) 2010-05-03
MX2009011692A (es) 2009-11-10
ZA200906739B (en) 2010-06-30
TN2009000427A1 (en) 2011-03-31
AU2008247603A1 (en) 2008-11-13
EP2142190A1 (en) 2010-01-13
JP2010526149A (ja) 2010-07-29

Similar Documents

Publication Publication Date Title
JP5876435B2 (ja) 骨髄腫の処置のためのｈｄａｃ阻害剤の使用
JP5784274B2 (ja) Ｈｄａｃ阻害剤と代謝拮抗剤の組み合わせ
US20100137398A1 (en) Use of hdac inhibitors for the treatment of gastrointestinal cancers
KR20100016171A (ko) 위장관암의 치료를 위한 ｈｄａｃ 억제제의 용도
KR20100017434A (ko) 골 파괴의 치료를 위한 ｈｄａｃ 억제제의 용도
AU2008204928B2 (en) Formulations of deacetylase inhibitors
KR20100016376A (ko) 흑색종의 치료를 위한 ｈｄａｃ 억제제의 용도
US20110124701A1 (en) Use of hdac inhibitors for the treatment of lymphomas

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid